Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Agj van der Zee is active.

Publication


Featured researches published by Agj van der Zee.


Cancer | 2002

Vulvar melanoma - Is there a role for sentinel lymph node biopsy?

J.A. de Hullu; Harry Hollema; Harald J. Hoekstra; Da Piers; Mje Mourits; Jan G. Aalders; Agj van der Zee

The objective of this study was to evaluate the authors recent, preliminary experience with the sentinel lymph node procedure in patients with vulvar melanoma and to compare this experience with treatment and follow‐up of patients with vulvar melanomas who were treated previously at their institution.


British Journal of Pharmacology | 2012

Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies.

Evelien W. Duiker; Ecf Dijkers; H Lambers Heerspink; S de Jong; Agj van der Zee; Pl Jager; Jgw Kosterink; Ege de Vries; M. N. Lub-de Hooge

BACKGROUND AND PURPOSE The TNF‐related apoptosis inducing ligand (TRAIL) induces apoptosis through activation of the death receptors, TRAIL‐R1 and TRAIL‐R2. Recombinant human (rh) TRAIL and the TRAIL‐R1 directed monoclonal antibody mapatumumab are currently clinically evaluated as anticancer agents. The objective of this study was to develop radiopharmaceuticals targeting the TRAIL‐R1, suitable for clinical use to help understand and predict clinical efficacy in patients.


Scandinavian Journal of Gastroenterology | 2001

Clinical Definition of Hereditary Non-polyposis Colorectal Cancer: A Search for the Impossible?

Mjw Berends; Ying Wu; Rolf H. Sijmons; Rmw Hofstra; Agj van der Zee; Chcm Buys; Jan H. Kleibeuker

Hereditary non-polyposis colorectal cancer is an autosomal dominant inherited disorder that predisposes its carriers to an almost 100% lifetime risk of cancer, in particular colorectal and endometrial cancer. Germline mutations, resulting in a deficient DNA mismatch repair system, are responsible for the disease. Because of the lack of specific phenotypical features, clinical diagnosis in an individual patient is impossible and relies heavily on family history. Genetic diagnosis by mismatch detection is now possible in a substantial proportion of families. Thus there is a great need for reliable but simple criteria that will help clinicians to recognize patients and families who can be referred for genetic diagnostics. In this article the different criteria that have been formulated and published in recent years are reviewed and the results, in terms of the proportions of subjects satisfying the criteria who were found to have a germline mutation, are discussed. In most studies the criteria were evaluated in only a small number of subjects. A population-based study is currently being carried out in the north of The Netherlands that aims to include 400 patients fulfilling one of a few simple criteria. Mutation analysis will be performed in all patients. The results of this study will help in the formulation of accurate and simple criteria for use in clinical practice.


British Journal of Obstetrics and Gynaecology | 2018

The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single-centre study

Annefloor W Pouwer; Rdm Mus; Joanna IntHout; Agj van der Zee; Johan Bulten; Lfag Massuger; J.A. de Hullu

To determine the efficacy of the addition of an ultrasound of the groins in routine follow up of women with vulvar squamous cell carcinoma (SCC) after a negative sentinel lymph node (SLN).


The Journal of Nuclear Medicine | 1998

Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva.

J.A. de Hullu; E Doting; Da Piers; H. Hollema; Jg Aalders; Agj van der Zee; H. Schraffordt Koops; J. Boonstra


International Journal of Gynecological Cancer | 2006

Molecular prognostic markers in ovarian cancer : toward patient-tailored therapy

Apg Crijns; Evelien W. Duiker; S de Jong; Phb Willemse; Agj van der Zee; Ege de Vries


International Journal of Oncology | 2003

Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours

G.B.A. Wisman; H. Hollema; Marco N. Helder; Aj Knol; Gt Van Der Meer; M. Krans; S de Jong; Ege de Vries; Agj van der Zee


Anticancer Research | 2004

Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer

Fyfl de Vos; A M E Bos; J. A. Gietema; Elisabeth Pras; Agj van der Zee; Ege de Vries; Phb Willemse


American Journal of Human Genetics | 2000

Germline hMLH3 mutations in patients with suspected HNPCC.

Ying Wu; Mjw Berends; Rgj Mensink; E Verlind; Rolf H. Sijmons; Agj van der Zee; Harry Hollema; Jan H. Kleibeuker; Chcm Buys; Rmw Hofstra


Anticancer Research | 1999

A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens

Gert-Jan Meersma; M Bakker; Hjm Groen; Agj van der Zee; Pb Jensen; G Giaccone; Ege de Vries; Ef Smit

Collaboration


Dive into the Agj van der Zee's collaboration.

Top Co-Authors

Avatar

J.A. de Hullu

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar

Chcm Buys

University of Groningen

View shared research outputs
Top Co-Authors

Avatar

Harry Hollema

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Jan H. Kleibeuker

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Mjw Berends

University of Groningen

View shared research outputs
Top Co-Authors

Avatar

Rmw Hofstra

University of Groningen

View shared research outputs
Top Co-Authors

Avatar

Rolf H. Sijmons

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Ying Wu

University of Groningen

View shared research outputs
Top Co-Authors

Avatar

H. Hollema

University of Groningen

View shared research outputs
Top Co-Authors

Avatar

Phb Willemse

University of Groningen

View shared research outputs
Researchain Logo
Decentralizing Knowledge